Manifold Bio
Jory Bell is a seasoned professional with extensive experience in venture capital and board governance. Currently serving as a General Partner at Playground Global since 2015, Jory Bell holds board member positions at several innovative companies, including Amber Bio, Atomic AI, Manifold Bio, Strand Therapeutics, Relativity Space, Ultima Genomics, and Mangata Networks. Additionally, Jory Bell contributes as a board observer for Infinimmune. Previous involvement includes serving on the board of Velo3D from 2016 to 2022. Jory Bell's academic background includes three Bachelor's Degrees in Earth, Atmosphere and Planetary Sciences, Architecture (Visual Art and Design), and Literature, all obtained from the Massachusetts Institute of Technology between 1986 and 1991.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Manifold Bio
2 followers
Manifold Bio's mission is to build technology that exponentially increases measurement throughput at all stages of drug development.